Related Experiment Video
Updated: Apr 26, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Deficient chaperone-mediated autophagy in liver leads to metabolic dysregulation
Jaime L Schneider1, Yousin Suh2, Ana Maria Cuervo1
1Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Institute for Aging Studies, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Abstract:
The activity of chaperone-mediated autophagy (CMA), a catabolic pathway for selective degradation of cytosolic proteins in lysosomes, decreases with age, but the consequences of this functional decline in vivo remain unknown. In this work, we have generated a conditional knockout mouse to selectively block CMA in liver. We have found that blockage of CMA causes hepatic glycogen depletion and hepatosteatosis. The liver phenotype is accompanied by reduced peripheral adiposity, increased energy expenditure, and altered glucose homeostasis. Comparative lysosomal proteomics revealed that key enzymes in carbohydrate and lipid metabolism are normally degraded by CMA and that impairment of their regulated degradation contributes to the metabolic abnormalities observed in CMA-defective animals. These findings highlight the involvement of CMA in regulating hepatic metabolism and suggest that the age-related decline in CMA may have a negative impact on the energetic balance in old organisms.
Insights
Chaperone-mediated autophagy (CMA) decline with age impairs liver metabolism, causing glycogen depletion and fat accumulation. This highlights CMA
Area of Science:
- Cellular Biology
- Metabolism
- Aging Research
Background:
- Chaperone-mediated autophagy (CMA) degrades cytosolic proteins but declines with age.
- The in vivo consequences of age-related CMA decline are not well understood.
Purpose of the Study:
- To investigate the in vivo role of CMA in hepatic metabolism.
- To determine the metabolic consequences of blocking CMA in the liver.
Main Methods:
- Generated a conditional knockout mouse model to selectively block CMA in hepatocytes.
- Utilized comparative lysosomal proteomics to identify CMA targets.
- Assessed metabolic parameters including glucose homeostasis and energy expenditure.
Main Results:
- CMA blockage in the liver led to hepatic glycogen depletion and hepatosteatosis.
- Mice with impaired CMA showed reduced peripheral adiposity and increased energy expenditure.
- Lysosomal proteomics revealed CMA degrades key metabolic enzymes, and their impaired degradation drives metabolic dysfunction.
Conclusions:
- CMA is crucial for regulating hepatic carbohydrate and lipid metabolism.
- Age-related decline in CMA may negatively impact the metabolic and energetic balance in aging organisms.
- Targeting CMA could offer therapeutic strategies for age-related metabolic disorders.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Lysosomal Hydrolases
Inborn Errors of Metabolism
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Hepatic Encephalopathy

